BACK TO CONGRESSES

Biennial International LRRK2 Meeting 2024

Jun 18 - 21, 2024 | Crete, Greece

The agents listed below are currently under investigation. Their safety and efficacy have not been established.

Presentation
Development of Potent, Orally Bioavailable PROTAC® LRRK2 Degrader Molecules as Potential Disease Modifying Therapeutics for Neurodegeneration

K Kelly